top of page

Dr Deep Jyoti Bhuyan

PhD, MSc, BSc
Senior Research Fellow - Healthy Ageing: Therapeutic Potential of Natural Products 

NICM Health Research Institute, Western Sydney University

Image.jpeg

Dr Bhuyan is a Senior Research Fellow, Higher Degree Research (HDR) Coordinator, and International Engagement Coordinator at the NICM Health Research Institute, Western Sydney University (WSU). He joined the institute in 2018 as an ARC Postdoctoral Research Fellow. In 2021, he established The GutBiotics Lab after receiving the WSU Research Support Program Fellowship. Dr Bhuyan's GutBiotics Lab explores the therapeutic potential of gut microbial metabolites (postbiotics). Understanding the effect of Bush foods and Australian traditional medicine on the gut microbiome and vice versa is another key focus of his lab. Furthermore, the GutBiotics Lab is developing natural product-based therapies for bacterial and viral diseases.

 

In 2023, he was appointed as the International Engagement Coordinator for NICM HRI to help strengthen the institute's partnership with India through research collaboration, engagement, policy development, and scholar exchange programs. Later, he served as the Acting HDR Director of NICM HRI, and in January 2024, he was appointed as the HDR Coordinator of the institute. In this role, he oversees a group of over 40 PhD, MRes and MPhil candidates along with the HDR Director of the institute.

 

Dr Bhuyan completed his PhD research at the University of Newcastle, where he explored the anticancer (against pancreatic adenocarcinoma) and antimicrobial properties of phenolic compounds and antioxidants in Australian Eucalyptus species. Currently, his research at NICM HRI is supported by grants from several government, industry, and university organizations, including the Australian Department of Industry, Science, Energy and Resources, the Therapeutic Goods Administration, Australia, and WSU. He has established collaborations with more than 40 international organizations worldwide.

 

Before coming to Australia, he worked as a Senior Research Fellow in probiotic food development at Assam Agricultural University on a National Agricultural Innovation Project funded by the Indian Council of Agricultural Research. His contributions extend to several peer-reviewed journal articles, invited book chapters and national and international conference presentations. He has also written for The Conversation on postbiotics, appeared in TV interviews and received wide media coverage. Currently, he provides supervision and guidance to 12 PhD and MRes students, two undergraduate students, and four Research Assistants while actively promoting science communication and STEM education.

Education

2008 Bachelor of Science Biotechnology, Bangalore University, India

2010 Master of Science Applied Microbiology, VIT University, India

2018 PhD in Food Science, The University of Newcastle, Australia

Research Focus

ma_0508_nf_holobiome_petridish_1280x720_

01

Gut Microbiota

How does gut microbiota affect the availability of nutrients? What is the role of gut microbiota-based strategies, such as prebiotics, probiotics, and postbiotics, in diseases such as cancer, diabetes, and metabolic syndrome?

Implementation of gut microbiota-derived postbiotics in cancer therapy and healthy ageing and understanding their molecular mechanisms of action using state-of-the-art techniques.

02

Postbiotics

Facilities-83_1_1_1024x_edited_edited.jp

Impact of phytochemicals and antioxidants, especially from Bush tucker on human health. Can fermentation improve the bioavailability of these phytochemicals and antioxidants?

science-research-leaves-mitragyna-specio

03

Phytochemicals and Antioxidants

Understanding how postbiotics and phytochemicals interact with standard drugs using advanced mathematical models and molecular assays.

04

Synergistic Mechanisms

AdobeStock_37033405_edited_edited_edited
800_iStock-481463882_edited_edited.jpg

05

Combination Therapy

Can we combine existing therapies for infectious diseases and cancer to improve efficacy (i.e., 1+1=3)?

Isolation and molecular characterisation of anticancer agents from sources such as Australian native plants and gut microbial communities.

06

Anticancer agents

laboratory-technician-labelling-cell-cul

Antiviral, antibacterial and antifungal properties of bioactive compounds and their interactions with standard antimicrobial agents.

Lab worker with petri dish_edited_edited

07

Antimicrobial Agents

Affiliations

2023 Joint Academic Microbiology Seminars Society

2023 Universal Scientific Education and Research Network

2023 Polyphenols Applications

2023 Committee Member, Joint Academic Microbiology Seminars Society

2022 Committee Member, NHMRC – Ideas Grants Peer Review Working Committee 2022

2022 International Society for Traditional, Complementary and Integrative Medicine Research

2020 NSW Cardiovascular Research Network, National Heart Foundation

2019 The Good Practice In Traditional Chinese Medicine Research Association

2017 Pharmacological Society of Singapore

2016 Institute of Food Technologists, Chicago, USA

2015 Australian Society of Medical Research

2014 Hunter Medical Research Institute

2014 Pancreatic Cancer Research Group, School of Environmental and Life Sciences, University of Newcastle, Australia

2010 Defence Research and Development Organisation, Ministry of Defence, India

Invited Scientific Expert, Hort Innovation and FOODiQ Global

Global Advisory Board Member, ViGA

Guest Editor, Frontiers in Nutrition

Guest Editor, Journal of Ayurveda and Integrative Medicine

Review Board Member, Cancers, MDPI

Review Board Member, Microorganisms, MDPI

Committee Member, Western Sydney University Microbiology Interest Society

Committee Member, Western Sydney University Microbiome Interest Group

Committee Member, National Science Centre Poland, European Commission

bottom of page